Evidence map›Paper›PMID 30867812›Full record

ArticleTheranostics2019

Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer.

Fengliu Deng, Rui Zhou, Chuang Lin, Shibin Yang, Hui Wang, Weidong Li, Kehong Zheng, Wandie Lin, Xin Li, Xueqing Yao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 161 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. FTO-mediated mClinical and translational medicine · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Fengliu DengDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Rui ZhouDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chuang LinDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shibin YangGastrointestinal Surgical Center, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Hui WangDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangzhou Medical University, Guangzhou, China.
Weidong LiDepartment of Medical Oncology, Affiliated Tumor Hospital of Guangzhou Medical University, Guangzhou, China.
Kehong ZhengDepartment of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wandie LinDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Xin LiDepartment of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Xueqing YaoDepartment of General Surgery, Guangdong General Hospital, Guangdong Academy of Medical Science, Guangzhou, China.
Mingxin PanSecond Department of Hepatobiliary Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Liang ZhaoDepartment of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Nanfang Hospital · CNGuangzhou Medical University Cancer Hospital · CNSouthern Medical University · CNZhujiang Hospital · CNGuangdong General Hospital · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis is a fundamental process that involves in tumor progression and metastasis. Vascular endothelial growth factor (VEGF) family and their receptors are identified as the most prominent regulators of angiogenesis. However, the clinical efficacy of anti-VEGF/VEGFR therapy is not ideal, prompting the needs to further understand mechanisms behind tumor angiogenesis. Here, we found that Dickkopf associated protein 2 (DKK2), a secretory protein highly expressed in metastatic colorectal cancer tissues, could stimulate angiogenesis via a classic VEGF/VEGFR independent pathway.

Indexed as

Neovascularization, PathologicAerobiosisColorectal NeoplasmsGene Expression ProfilingGlycolysisHistocytochemistryHumansIntercellular Signaling Peptides and ProteinsMicroarray AnalysisMicroscopy, FluorescenceDKK2 protein, humanIntercellular Signaling Peptides and ProteinsAerobic GlycolysisAngiogenesisColorectal cancerDickkopf 2Vascular endothelial growth factor

Identifiers

PMID30867812
PMCPMC6401398
OpenAlexW2911292434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.